Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $112.5800 (-0.71%) ($112.5800 - $114.9800) on Tue. May. 28, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.56% (three month average) | RSI | 32 | Latest Price | $112.5800(-0.71%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | LGND declines -1.9% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(60%) IWO(57%) XBI(55%) IWC(54%) IWM(53%) | Factors Impacting LGND price | LGND will decline at least -1.28% in a week (0% probabilities). VXX(-21%) TLT(-15%) VIXM(-9%) IFRA(-8%) UUP(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.28% (StdDev 2.56%) | Hourly BBV | 0 () | Intraday Trend | -0.5% | | | |
|
1 - 5 Day Possible Target | $107.47(-4.54%) | Resistance Level | $117.36 | 5 Day Moving Average | $113.52(-0.83%) | 10 Day Moving Average | $113.81(-1.08%) | 20 Day Moving Average | $117.36(-4.07%) | To recent high | -13% | To recent low | 6.3% | Market Cap | $1.809b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |